-
FDA Approves Zeposia (Ozanimod), Oral Therapy for All with Relapsing MS
News, SPMSThe U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral capsules to treat adults with relapsing forms ... Read more -
Canada Rules EHP-101, Potential Cannabidiol Treatment, Not Controlled Substance
NewsEHP-101, a cannabidiol-derived investigational therapy being developed by Emerald Health Pharmaceuticals (EHP) to treat multiple sclerosis (MS), is not a controlled ... Read more -
Bile Acid Supplements May Ease Symptoms of Progressive MS
NewsMultiple sclerosis (MS) patients have lower than usual levels of molecules called bile acids circulating in their blood, a study ... Read more -
MS News that Caught My Eye Last Week: COVID-19 and MS, Zeposia Approved, Talk Therapy, Temelimab Trial Postponed
Columns, The MS Wire - A Column by Ed TobiasAs the COVID-19 pandemic swirls around us, we will continue to provide our readers with information about the novel ... Read more -
CHMP Favors Zeposia (Ozanimod) as Oral Treatment for Active RRMS in EU
NewsThe Committee for Medicinal Products for Human Use (CHMP) has recommended Zeposia (ozanimod) oral capsules to be approved in the ... Read more -
Way of Getting Nerve Cells to Restore Myelin-like Abilities Seen as Possible
NewsResearchers developed a way of reprograming cells to use synthetic materials — provided by the team — to create ... Read more -
Do They Know It’s Not Christmas?
Columns, Fall Down, Get Up Again- a Column by John ConnorQuarantine sure feels like Christmas. The shops are stripped bare. The streets are empty. Family homes are stuffed with ... Read more -
Online Coronavirus Screening May Not Be Ready for Prime Time
Columns, The MS Wire - A Column by Ed TobiasA number of websites are currently offering online coronavirus screening. These aren’t a full-scale test. The online sites read ... Read more -
Mix of Broad and Specific Language May Help in Talking About MS
NewsUsing a mix of broad diagnostic terms and more disease-specific ones may help physicians and patients to better communicate symptoms ... Read more -
Potential Competitor to Acthar Gel Asking to Re-enter US Market
NewsANI Pharmaceuticals is asking the U.S. Food and Drug Administration (FDA) for the right to reintroduce in the U.S. ... Read more -
Need to Know: MS and the Battlefield of the Immune System
Columns, MS in Moderation – a Column by Tamara SellmanEditor’s note: “Need to Know” is a series inspired by common forum questions and comments from readers. Have a ... Read more -
A Life Unscripted: Choosing Positivity During a Pandemic
Columns, Silver Linings - a Column by Jennifer PowellLife is unscripted. It is messy and uncertain, with change being the only constant. Much like living with multiple ... Read more -
Helius Medical Technologies Authorized by Heath Canada to Market PoNS Device
NewsThe neurotechnology company Helius Medical Technologies has received authorization from Health Canada to market its portable neuromodulation stimulator (PoNS) device to ... Read more
